University of Cincinnati
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Cincinnati sits in the top decile of US sponsors by registered trial count (#133 of 15,742 sponsors by registered trial count).
University of Cincinnati: 245 sponsored US clinical trials, 34 recruiting.
University of Cincinnati sponsors 245 registered US clinical trials on ClinicalTrials.gov, 34 of them currently recruiting, and 172 completed. 65 of these trials are in Phase 3-4 (later-stage) and 56 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 9 trials.
Top-decile sponsor footprint
University of Cincinnati ranks in the top decile of sponsors by registered trial count (#133 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
172 of 189 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
245 total, page 3 of 5
Spreading Depolarizations in Traumatic Brain Injury
NCT03379220
A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses
NCT02922959
Recurrent Atrial Fibrillation
NCT02898545
Mechanisms of Walking Recovery After Stroke
NCT02858349
Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis
NCT03052101
Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients
NCT02412982
Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients
NCT02147132
OnabotulinumtoxinA in the Management of Psychogenic Dystonia
NCT02618889
Treating Bacterial Overgrowth in Parkinson's Disease
NCT02470780
Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth
NCT02553161
Anti-gravity Treadmill Exercise in Stress Myocardial Perfusion Imaging
NCT02628002
Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder
NCT02478788
Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome
NCT03040115
Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT02325401
Neurofunctional Predictors of Escitalopram Treatment Response in Adolescents With Anxiety
NCT02818751
Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients
NCT02014103
Pericardial Fat and Inflammation in HIV Patients and Controls
NCT02399384
Phone Interview to Prevent Recurring Opioid Overdoses
NCT02282306
Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body
NCT02208024
Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors
NCT02071537
Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy
NCT02221583
Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck
NCT02110992
Ketamine Patient-Controlled Analgesia for Acute Pain
NCT02062879
Mindfulness in Mood Dysregulated Youth
NCT02120937
Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
NCT01979211
High Intensity Interval Training in Chronic Stroke
NCT01958606
Effect of Omega-3 Fatty Acid on Cortical Function in ADHD
NCT01883817
Asenapine for Bipolar Depression
NCT01807741
Mindfulness Based Cognitive Therapy for Youth With Anxiety at Risk for Bipolar Disorder
NCT02090595
Retraining Attention to Treat Alcohol Dependence and Social Anxiety
NCT01886716
SGA-induced Metabolic Syndrome in Bipolar Youth
NCT01858948
Pharmacokinetic Studies of Tacrolimus in Transplant Patients
NCT01889758
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design
NCT01713777
Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure
NCT01814319
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
NCT01733394
Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation
NCT02524977
Belatacept Early Steroid Withdrawal Trial
NCT01729494
Non-Invasive Hemoglobin Monitoring in Patients With Hemorrhage
NCT01709786
Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence
NCT01641159
Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections
NCT01549613
Rehabilitative Ultrasound Imaging: Measurements of Articular Movement of the Shoulder
NCT02338791
Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage
NCT01565590
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
NCT01517529
Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors
NCT01508104
Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics
NCT01457053
Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects
NCT01477450
Enhanced Critical Care Air Transport Team Training for Mitigation of Task Saturation
NCT01628224
A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men
NCT01431079
Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
NCT01508117
Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis
NCT01508221
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 33 |
| Phase 3 | 19 |
| Phase 4 | 46 |
Therapeutic Areas
What is open in the University of Cincinnati pipeline
34 recruiting of 245 indexed (14% open); 172 completed (70%).
Phase mix: 65 late (III/IV) vs 56 early (I/II) (balanced across stages).
Top condition: Stroke (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Cincinnati: open-pipeline peers nationwide
Peers matched on 245 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
University of Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 245 trials (± recruiting share)
- Shire · 245 trials · 0% recruiting
- State University of New York at Buffalo · 243 trials · 21% recruiting
- Masonic Cancer Center, University of Minnesota · 249 trials · 14% recruiting
- University of Massachusetts, Worcester · 240 trials · 13% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Milton S. Hershey Medical Center · 14% recruiting · 396 trials
- Johns Hopkins Bloomberg School of Public Health · 14% recruiting · 187 trials
- BeiGene · 14% recruiting · 65 trials
- Seattle Institute for Biomedical and Clinical Research · 14% recruiting · 43 trials
Related
What to do with this University of Cincinnati page
245 registered trials is a research-attention snapshot, not an endorsement of University of Cincinnati or any single study.
- 34 of University of Cincinnati's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition University of Cincinnati studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Cincinnati pipeline card: 245 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.